Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Neurofilaments are type IV intermediate filament heteropolymers composed of light, medium, and heavy chains. Additionally we are shipping Neurofilament, Light Polypeptide Kits (26) and Neurofilament, Light Polypeptide Proteins (9) and many more products for this protein.
Showing 10 out of 224 products:
Bird (Avian) Polyclonal NEFL Primary Antibody for ICC, IF - ABIN152477
King, Dickson, Blizzard, Woodhouse, Foster, Chung, Vickers: Neuron-glia interactions underlie ALS-like axonal cytoskeletal pathology. in Neurobiology of aging 2011
Show all 7 references for ABIN152477
Human Monoclonal NEFL Primary Antibody for IHC (fro), IHC (p) - ABIN1108415
Zhu, Couillard-Després, Julien: Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. in Experimental neurology 1998
Show all 3 references for ABIN1108415
Cat (Feline) Monoclonal NEFL Primary Antibody for IHC (fro), IHC (p) - ABIN114492
Luider, van Dommelen, Tibboel, Meijers, Ten Kate, Trojanowski, Molenaar: Differences in phosphorylation state of neurofilament proteins in ganglionic and aganglionic bowel segments of children with Hirschsprung's disease. in Journal of pediatric surgery 1992
Show all 3 references for ABIN114492
Bird (Avian) Monoclonal NEFL Primary Antibody for ICC, IF - ABIN152478
King, Dickson, Blizzard, Foster, Chung, West, Chuah, Vickers: Excitotoxicity mediated by non-NMDA receptors causes distal axonopathy in long-term cultured spinal motor neurons. in The European journal of neuroscience 2007
Show all 3 references for ABIN152478
Chicken Monoclonal NEFL Primary Antibody for IF, WB - ABIN371827
Harris, Ayyub, Shaw: A molecular dissection of the carboxyterminal tails of the major neurofilament subunits NF-M and NF-H. in Journal of neuroscience research 1992
Show all 2 references for ABIN371827
Cow (Bovine) Polyclonal NEFL Primary Antibody for IHC (fro), IF - ABIN372673
Mersiyanova, Perepelov, Polyakov, Sitnikov, Dadali, Oparin, Petrin, Evgrafov: A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. in American journal of human genetics 2000
Show all 2 references for ABIN372673
Human Monoclonal NEFL Primary Antibody for ICC, FACS - ABIN969548
Lee, Kim, Chung, Kim, Kwon, Min, Chang: The effect of rod domain A148V mutation of neurofilament light chain on filament formation. in BMB reports 2009
Show all 2 references for ABIN969548
Cow (Bovine) Polyclonal NEFL Primary Antibody for IF, WB - ABIN488087
Shaw, Yang, Ellis, Anderson, Parker Mickle, Scheff, Pike, Anderson, Howland: Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. in Biochemical and biophysical research communications 2005
Human Monoclonal NEFL Primary Antibody for EIA, FACS - ABIN1108417
Abe, Numakura, Saito, Koide, Oka, Honma, Kishikawa, Hayasaka: Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease: nonsense mutation probably causes a recessive phenotype. in Journal of human genetics 2009
Nefl(N98S/+) mice had a noticeable tremor, and most animals showed a hindlimb clasping similar to human Charcot-Marie-Tooth Type 2E phenotype.
The finding of this study suggested that a lack of NFL protein alters the expression of cytoskeletal proteins and disrupts other NF subunits, causing intracellular aggregation but not gross structural changes in cortical neurons or cytoarchitecture.
Neurofilament light chain (NFL) and neuronal intermediate filament protein (show GFAP Antibodies) alpha-internexin (show INA Antibodies) accumulate in axon swellings in the spinal white matter in a superoxide dismutase (SOD)-1 (show SOD1 Antibodies) mouse model.
Data suggest that tetrahydropapaveroline (an endogenous catechol) causes oxidative stress resulting in astrocyte/neuronal cell death via generation of reactive oxygen species and modification/aggregation of NF-L (as in neurodegenerative diseases).
Data show that mitochondria essentially stopped moving in neurons expressing neurofilament protein (NFL) mutants, probably a consequence of cytoskeletal disruption.
Myo (show SYNPO2 Antibodies) Va interactions with intermediate filament proteins may serve similar roles in organizing organelle topography in different cell types.
NEFL transgenic mice exhibited extended duration of the hindlimb clasping response and gait anomalies, as well as sensorimotor deficits in stationary beam and suspended bar tests
Neuropathic effects of overexpressing NF-L can occur at the level of transgene RNA and are mediated by sequences in the NF-L 3' UTR (show UTS2R Antibodies)
nNOS (show NOS1 Antibodies) inhibitor, AR-R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum
The 3' untranslated region of light neurofilament (NF-L) transcript enhances the reactivity of its own translated product and leads to loss of solubility and aggregation of NF-L protein and to coaggregation of mutant superoxide dismutase 1 (SOD1 (show SOD1 Antibodies)) protein
We conclude that the NEFL N98S mutation is associated with a dominant intermediate Charcot-Marie-Tooth disease phenotype characterized by early-onset sensorimotor neuropathy delaying motor milestones, which may evolve into a severe and complex clinical picture including cerebellar ataxia (show USP14 Antibodies).
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection
The results showed an important role for miR (show MLXIP Antibodies)-25 in regulating NEFL expression in Glioblastoma multiforme.
Finally, we demonstrated that NEFL inhibited the NF-kappaB (show NFKB1 Antibodies) pathway, thereby suppressing the expression of uPA (show PRAP1 Antibodies) and decreasing NSCLC invasiveness and migration.
Cerebrospinal fluid NFL concentration is increased by the early clinical stage of Alzheimer's Disease.
The miR (show MLXIP Antibodies)-381-NEFL axis is important for temozolomide resistance in glioblastoma multiforme.
The results od this study concluded that NEFL E396K mutation may manifest with a novel DI-CMT phenotype, characterized by simultaneous involvement of the peripheral and central nervous system.
Suggest monitoring the serum level of antibodies against the NF-L chain as a predictive biomarker of treatment response in multiple sclerosis.
a novel heterozygous missense mutation c.1166A>G (p.Y389C) in the gene encoding the light-chain neurofilament protein was identified in 4 patients resulting in hereditary motor and sensory neuropathy with pyramidal signs phenotype.
Data suggest that, while lacking a stable structure, NFL-TBS (show SALL1 Antibodies).40-63 peptide (a peptide derived from light neurofilament protein) preferentially binds on a specific single site located near C-terminal end of beta-tubulin (show TUBB Antibodies).
Neurofilaments are type IV intermediate filament heteropolymers composed of light, medium, and heavy chains. Neurofilaments comprise the axoskeleton and they functionally maintain the neuronal caliber. They may also play a role in intracellular transport to axons and dendrites. This gene encodes the light chain neurofilament protein. Mutations in this gene cause Charcot-Marie-Tooth disease types 1F (CMT1F) and 2E (CMT2E), disorders of the peripheral nervous system that are characterized by distinct neuropathies. A pseudogene has been identified on chromosome Y.
neurofilament, light polypeptide 68kDa
, neurofilament, light polypeptide
, neurofilament light polypeptide
, 68 kDa neurofilament protein
, neurofilament protein L
, neurofilament triplet L protein
, light molecular weight neurofilament protein
, neurofilament protein, light chain
, neurofilament subunit NF-L
, micro glutamic acid-rich protein
, neurofilament protein
, Neurofilament triplet L protein